<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03701620</url>
  </required_header>
  <id_info>
    <org_study_id>HSJ 2018-1575</org_study_id>
    <nct_id>NCT03701620</nct_id>
  </id_info>
  <brief_title>Heart Rate Variability in Children With Traumatic Brain Injury</brief_title>
  <acronym>HRV-TBI</acronym>
  <official_title>Heart Rate Variability in Children With Traumatic Brain Injury and Neurological Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Justine's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Justine's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using a prospective cohort of children admitted to the PICU, the investigators will determine
      HRV monitoring is feasible, if a decreased HRV in the 7 days following moderate or severe TBI
      in children is associated with a worse outcome 6 months post-TBI and investigate HRV as a
      tool that can predict adverse events (neurological crisis) within 2 days following TBI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center prospective cohort study of 15 children &lt;18 years, admitted to the
      PICU at the CHU Sainte-Justine (CHUSJ) with moderate or severe TBI (&lt;24 hours).
      Neurodevelopment outcome of children will be evaluated 6 months post TBI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>% of the time with reliable HRVmonitoring in children with TBI</measure>
    <time_frame>1 year</time_frame>
    <description>Feasibility of having a reliable capture and analysis of HRV 7 days post TBI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of adverse events preceded by a decreased HRV</measure>
    <time_frame>1 year</time_frame>
    <description>Adverse events will be defined as increased intracranial pressure, decreased CPP, seizure and cardiac arrest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HRV and neurological outcome</measure>
    <time_frame>1.5 year</time_frame>
    <description>The primary outcome of neurological and functional outcome will be assessed by the Pediatric Glasgow Outcome Scale Extended (P-GOSE) 6 months post TBI. P-GOSE is an 8-point ordinal scale (1= best outcome) The score will be classified as favourable (P-GOSE 1 or 2, or decreased of P-GOSE of 1 point post PICU (∆ P-GOSE ≤1) or unfavourable (P-GOSE ≥3 or ∆ P-GOSE ≥2)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Child Development</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>HRV monitoring</intervention_name>
    <description>HRV monitoring derived from electrocardiogram</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children requiring PICU admission after TBI
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt;18 years

          -  admitted to the PICU at the CHUSJ

          -  moderate TBI (Glasgow Coma Scale (GCS): 9-12) or severe TBI (GCS ≤8) as - - assessed
             30 minutes after TBI or upon arrival in the emergency room

          -  written parental consent.

        Exclusion Criteria:

          -  children fulfilling brain death criteria at the time of PICU admission (GCS 3 and loss
             of all brain stem reflexes)

          -  children with a pacemaker or with previously diagnosed arrhythmia (HRV monitoring not
             reliable)

          -  inflicted trauma (different underlying pathophysiology)

          -  patients or parents who do not speak or read English or French.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence Ducharme-Crevier</last_name>
    <phone>514-345-4931</phone>
    <phone_ext>4118</phone_ext>
    <email>lducharmecrevier@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Sainte-Justine</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Ducharme-Crevier</last_name>
      <phone>514-345-4931</phone>
      <phone_ext>4118</phone_ext>
      <email>lducharmecrevier@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 3, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2018</study_first_posted>
  <last_update_submitted>October 8, 2018</last_update_submitted>
  <last_update_submitted_qc>October 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Justine's Hospital</investigator_affiliation>
    <investigator_full_name>Laurence Ducharme-Crevier</investigator_full_name>
    <investigator_title>Pediatric intensivist, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

